Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants-Reference-Cited by-同舟云学术

Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants

Published:2021-11-03 Issue:618 Volume:13 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Chandrashekar Abishek¹^ORCID,Liu Jinyan¹^ORCID,Yu Jingyou¹^ORCID,McMahan Katherine¹^ORCID,Tostanoski Lisa H.¹^ORCID,Jacob-Dolan Catherine¹²^ORCID,Mercado Noe B.¹^ORCID,Anioke Tochi¹^ORCID,Chang Aiquan¹²^ORCID,Gardner Sarah¹,Giffin Victoria M.¹^ORCID,Hope David L.¹^ORCID,Nampanya Felix¹,Patel Shivani¹^ORCID,Sanborn Owen¹,Sellers Daniel¹^ORCID,Wan Huahua¹^ORCID,Martinot Amanda J.³^ORCID,Baczenas John J.⁴^ORCID,O’Connor Shelby L.⁴^ORCID,Pessaint Laurent⁵^ORCID,Valentin Daniel⁵,Espina Benjamin⁵,Wattay Lauren⁵^ORCID,Ferrari Maria G.⁵^ORCID,Brown Renita⁵,Cook Anthony⁵,Bueno-Wilkerson Deandre⁵,Teow Elyse⁵,Andersen Hanne⁵^ORCID,Lewis Mark G.⁵^ORCID,Barouch Dan H.¹²⁶^ORCID

Affiliation:

1. Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

2. Harvard Medical School, Boston, MA 02115, USA.

3. Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.

4. Wisconsin National Primate Research Center and University of Wisconsin, Madison, WI 53711, USA.

5. BIOQUAL, Rockville, MD 20852, USA.

6. Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.

Abstract

SARS-CoV-2 WA1/2020 infection of rhesus macaques partially protects against reinfection with SARS-CoV-2 variants.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference23 articles.

1. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

2. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

3. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

4. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

5. Neutralizing Activity of BNT162b2-Elicited Serum

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters;PLOS Pathogens;2024-01-10

2. Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice;Viral Immunology;2023-10-01

3. Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2;Nature Communications;2023-09-26

4. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection;Cell;2023-05

5. Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters;Nature Communications;2022-11-10